New hepatitis C treatment approved

liver cancer: "liver" spelled out on post-its hanging from line
The  TGA has approved a new hepatitis C treatment, Gilead Sciences, Australia New Zealand, today announced. Harvoni (ledipasvir/ sofosbuvir) is the first daily single tablet regimen for the treatment of genotype one chronic hepatitis C (HCV) in adults. In clinical trials, it was shown that up to 99% of patients with HCV genotype one taking

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacists' Support Service thanks volunteers
Next Pymble Public School in hearty stunt